Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-08-058192
Filing Date
2008-10-31
Accepted
2008-10-31 17:48:48
Documents
2
Period of Report
2008-10-22

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c76588_3x1.html 3  
1 MAIN DOCUMENT DESCRIPTION c76588_3x1.xml 3 2612
2 POWER OF ATTORNEY c76588_24.htm EX-24 6265
  Complete submission text file 0001209191-08-058192.txt   10509
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 950 PARK AVE APT. 11A NEW YORK NY 10028
Business Address
KESSEL MARK (Reporting) CIK: 0001222013 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21990 | Film No.: 081155667